Data / Form D filings / PharmassetX Inc.
PharmassetX Inc.: Form D filings
PharmassetX Inc., a pharmaceuticals company in Louisville, KY, filed 2 Form D notices with the SEC between 2025 and 2026. The latest, on May 4, 2026, reports $100,000 sold of a $6 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2900 LAKE VISTA DRIVE, Louisville, KY, 40241
- Phone
- (502) 939-1925
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2024
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2090938
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 4, 2026 | New notice | $6,000,000 | $100,000 | $5,900,000 | 1 | Apr 30, 2026 | sec.gov |
| Oct 10, 2025 | New notice | $20,000,000 | $50,000 | $19,950,000 | 1 | Sep 10, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Terry Minton | Executive Officer, Director | Chief Executive Officer |
| David McClure | Executive Officer, Director | Chief Operating Officer |
| Gerald Dryden | Executive Officer, Director | Chief Medical Officer |
Every Form D from the week of May 4, 2026 · All recent filings in Kentucky · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what PharmassetX Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.